Abgenex

Bhubaneswar, India Founded: 2013 • Age: 13 yrs
Antibodies and molecular biology reagents are developed and manufactured.

About Abgenex

Abgenex is a Healthcare company based in Bhubaneswar (India) founded in 2013 by Sujay Singh. Antibodies and molecular biology reagents are developed and manufactured. Its Indian entity Abgenex Private Limited reported revenue of β‚Ή1.35 Cr. Abgenex offers products and services including Antibodies, Cell Lines, Recombinant Proteins, and Research Kits. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents.

Company details

Abgenex was founded in 2013 and is based in Bhubaneswar, India. Operations focus on the biotechnology sector, where antibodies, molecular biology kits, cell lines, proteins, and tissue microarrays are developed and produced. Custom services are provided, including monoclonal and polyclonal antibody development, epitope design, peptide synthesis, stable cell line generation, protein production, and immunohistochemistry. Fast-track screening for monoclonal antibody production and in vitro drug discovery screening are also offered.

  • Headquarters Bhubaneswar, India
  • Founders Sujay Singh
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website abgenex.com
  • Social LinkedIn X Facebook
  • Legal Name Abgenex Private Limited
  • Date of Incorporation 25 Nov, 2002
  • Jurisdiction Bhubaneswar, Odisha, India
Key Metrics
  • Annual Revenue
    ₹1.35 Cr

    FY 2025 · +5% YoY

  • Net Profit
    ₹5.7 Lakh

    FY 2025 · 4% margin

  • EBITDA
    ₹6.4 Lakh

    FY 2025 · 5% margin

Products & Services of Abgenex

Abgenex offers a comprehensive portfolio of products and services, including Antibodies, Cell Lines, Recombinant Proteins, and Research Kits.

Antibodies
Biotech Products

High-quality antibodies for research and diagnostics purposes

Cell Lines
Cell Culture

Stable cell lines for various biological assays and studies

Recombinant Proteins
Biotech Products

Proteins for bio-activity assays and stem cell research

Research Kits
Reagents

Kits for ELISA, apoptosis detection, and flow cytometry

Board of directors of Abgenex Private Limited (Abgenex)

Abgenex Private Limited is the primary company behind Abgenex. The board of Abgenex Private Limited currently have 5 directors; the longest-serving is Sujay Kumar Singh, appointed in 2002. 4 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Sujay Kumar Singh
DIN 00616056
Director25 Nov 200223 yrs 11 moAbgenex Private Limited
Gita Singh
DIN 03625506
Director02 Jan 201214 yrs 10 moAbgenex Private Limited
Subrat Kumar Kar
DIN 06855597
Director27 Feb 201511 yrs 8 moAbgenex Private Limited
Jabed Akhtar
DIN 06855580
Director27 Feb 201511 yrs 8 moAbgenex Private Limited
Prasanta Kumar Maiti
DIN 06855565
Director27 Jul 20188 yrs 3 moAbgenex Private Limited

People of Abgenex

1 people are tracked at Abgenex (1 in leadership).

NameRoleGroup
Founder & DirectorLeadership
Premium access

Complete people profiles for Abgenex

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Abgenex

Figures of Abgenex Private Limited, the primary company behind Abgenex, for FY 2025. Revenue was ₹1.35 Cr (+5% year on year). Net profit was ₹5.7 Lakh (4% margin). EBITDA was ₹6.4 Lakh (5% margin). Revenue has grown at a compounded annual rate of -5% over three years and +7% over five years.

  • ₹1.35 CrRevenue · FY 2025 · +5% YoY
  • ₹5.7 LakhNet profit · 4% margin
  • ₹6.4 LakhEBITDA · 5% margin
  • ₹1 LakhPaid-up capital
  • 2Employees (provident fund records)
  • -5%Revenue CAGR, 3 years
  • +7%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Abgenex Private Limited are on its company page.

Premium access

Detailed financial statements for Abgenex

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of Abgenex

The website of Abgenex (abgenex.com) receives about 4.4K visits a month.

  • Monthly visits
    4.4K

    ▲ 3.1% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Abgenex

Abgenex was founded in 2013.

Abgenex is headquartered in Bhubaneswar, India. It is registered at Bhubaneswar, Odisha, India.

The primary company behind Abgenex, Abgenex Private Limited, reported revenue of β‚Ή1.35 Cr for FY 2025, up 5% year on year.

Abgenex was founded in 2013 and is based in Bhubaneswar, India. Operations focus on the biotechnology sector, where antibodies, molecular biology kits, cell lines, proteins, and tissue microarrays are developed and produced. Custom services are provided, including monoclonal and polyclonal antibody development, epitope design, peptide synthesis, stable cell line generation, protein production, and immunohistochemistry. Fast-track screening for monoclonal antibody production and in vitro drug discovery screening are also offered.

Abgenex offers Antibodies, Cell Lines, Recombinant Proteins, and Research Kits.

Abgenex operates through Abgenex Private Limited.

The legal entities of Abgenex currently have 5 directors, including Gita Singh, Subrat Kumar Kar, Prasanta Kumar Maiti and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available